Skip to main content
Clinical Trials/JPRN-UMIN000025083
JPRN-UMIN000025083
Completed
Phase 4

A study of long-term efficacy and safety of calcipqotriol hydrate/betamethasone dipropionate ester fixed dose combination product in patients with psoriasis vulgaris - A study of long-term efficacy and safety of calcipqotriol hydrate/betamethasone dipropionate ester fixed dose combination product in patients with psoriasis vulgaris

Fukuoka University0 sites100 target enrollmentMay 15, 2017

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
psoriasis vulgaris
Sponsor
Fukuoka University
Enrollment
100
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 15, 2017
End Date
May 31, 2016
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) pregnant, or possibly pregnant women 2\) subjects contraindicated by package insert 3\) subjects judged unsuitable by physicians 4\) subjects who are going to receive oral or injective steroid, cyclosporine, methotrexate, biologics, ultraviolet therapy, herbal medication against psoriasis within the trial period., 5\) subjects who used Dovobet within 4 weeks before starting the trial.

Outcomes

Primary Outcomes

Not specified

Similar Trials